Fed Regist. 1997 Dec 12;62(239):65384-8.
The Food and Drug Administration (FDA) is proposing to amend its regulations regarding preemption of State and local requirements applicable to medical devices. This action is being taken to clarify and codify the agency's longstanding position that available legal remedies, including State common law tort claims, generally are not preempted under the Federal Food, Drug, and Cosmetic Act (the act).
美国食品药品监督管理局(FDA)提议修订其关于取代适用于医疗器械的州和地方法规的规定。采取这一行动是为了澄清并编纂该机构的长期立场,即包括州普通法侵权索赔在内的现有法律补救措施,一般不在《联邦食品、药品和化妆品法案》(该法案)规定的取代范围内。